Efficacy and Safety of Aqueous Interleukin-8-Guided Treatment in Cytomegalovirus Retinitis after Bone Marrow Hematopoietic Stem Cell Transplantation

References

• Kotton CN, Kumar D, Caliendo AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102(6):900–931. doi:10.1097/tp.0000000000002191.
   PubMed Web of Science ®Google Scholar
• Mori T. Management of cytomegalovirus infection after hematopoietic stem cell transplantation. [Rinsho ketsueki] Jpn J Clinical Hematoly. 2019;60:1337–1340. doi:10.11406/rinketsu.60.1337.
   PubMedGoogle Scholar
• Diaz L, Rosales J, Rosso F, et al. Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years. Hematol Transfus Cell Ther. 2020;42(1):18–24. doi:10.1016/j.htct.2018.10.004.
   PubMedGoogle Scholar
• Yan CH, Wang Y, Mo XD, et al. Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020;55(6):1147–1160. doi:10.1038/s41409-020-0790-z.
   PubMed Web of Science ®Google Scholar
• Boeckh M, Bowden R. Cytomegalovirus infection in marrow transplantation. Cancer Treat Res. 1995;76:97–136.
   PubMedGoogle Scholar
• Port AD, Orlin A, Kiss S, Patel S, D’Amico DJ, Gupta MP. Cytomegalovirus retinitis: a review. J Ocul Pharmacol Ther. 2017;33(4):224–234. doi:10.1089/jop.2016.0140.
   PubMed Web of Science ®Google Scholar
• Kim DY, Jo J, Joe SG, Kim JG, Yoon YH, Lee JY. Comparison of visual prognosis and clinical features of cytomegalovirus retinitis in hiv and non-HIV patients. Retina (Philadelphia, Pa). 2017;37(2):376–381. doi:10.1097/iae.0000000000001144.
   PubMed Web of Science ®Google Scholar
• Choopong P, Vivittaworn K, Konlakij D, Thoongsuwan S, Pituksung A, Tesavibul N. Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis. BMC Infect Dis. 2016;16(1). doi:10.1186/s12879-016-1490-6.
   PubMedGoogle Scholar
• Arevalo JF, Garcia RA, Mendoza AJ. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Eur J Ophthalmol. 2005;15(5):610–618. doi:10.1177/112067210501500512.
   PubMed Web of Science ®Google Scholar
• Ljungman P, de la Camara R, Robin C, et al. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). The Lancet Infectious Diseases 2019;19:e260–e272. DOI 10.1016/s1473-3099(19)30107-0
   Google Scholar
• Iyer JV, Connolly J, Agrawal R, et al. Cytokine analysis of aqueous humor in HIV patients with cytomegalovirus retinitis. Cytokine. 2013;64(2):541–547. doi:10.1016/j.cyto.2013.08.006.
   PubMed Web of Science ®Google Scholar
• Wang B, Tian B, Tao Y, Hou J, Zhao XT, Li XX. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis. J Ocul Pharmacol Ther. 2014;30(7):587–592. doi:10.1089/jop.2013.0241.
   PubMed Web of Science ®Google Scholar
• Pei XY, Zhao XY, Chang YJ, et al. Cytomegalovirus-specific T-cell transfer for refractory cytomegalovirus infection after haploidentical stem cell transplantation: the quantitative and qualitative immune recovery for cytomegalovirus. J Infect Dis. 2017;216:945–956. doi:10.1093/infdis/jix357.
   PubMed Web of Science ®Google Scholar
• Liu J, Kong J, Chang YJ, et al. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect. 2015;21(12):1121.e1129-1115. doi:10.1016/j.cmi.2015.06.009.
   Web of Science ®Google Scholar
• Okamoto T, Okada M, Mori A, et al. Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient. Bone Marrow Transplant. 1997;20(9):801–803. doi:10.1038/sj.bmt.1700967.
   PubMed Web of Science ®Google Scholar
• Ju HY, Kang HJ, Hong CR, et al. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation. Transplant Infect Dis. 2016;18(3):396–404. doi:10.1111/tid.12539.
   PubMed Web of Science ®Google Scholar
• Ganly PS, Arthur C, Goldman JM, Schulenburg WE. Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation. Postgrad Med J. 1988;64(751):389–391. doi:10.1136/pgmj.64.751.389.
   PubMed Web of Science ®Google Scholar
• Larochelle MB, Phan R, Craddock J, et al. Cytomegalovirus retinitis in pediatric stem cell transplants: report of a recent cluster and the development of a screening protocol. Am J Ophthalmol. 2017;175:8–15. doi:10.1016/j.ajo.2016.09.039.
   PubMed Web of Science ®Google Scholar
• Jeon S, Lee WK, Lee Y, Lee DG, Lee JW. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation. Ophthalmology. 2012;119(9):1892–1898. doi:10.1016/j.ophtha.2012.03.032.
   PubMed Web of Science ®Google Scholar
• Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transplant Infect Dis. 2008;10(1):13–18. doi:10.1111/j.1399-3062.2007.00241.x.
   PubMed Web of Science ®Google Scholar
• Hiwarkar P, Gajdosova E, Qasim W, et al. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Clin Infect Dis. 2014;58(12):1700–1706. doi:10.1093/cid/ciu201.
   PubMed Web of Science ®Google Scholar
• Kim T, Lee YM, Lee SO, et al. Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy. Korean J Intern Med. 2016;31(5):961–970. doi:10.3904/kjim.2015.079.
   PubMed Web of Science ®Google Scholar
• Pearce WA, Yeh S, Fine HF. Management of cytomegalovirus retinitis in HIV and Non-HIV patients. Ophthalmic Surg Lasers Imaging Retina. 2016;47(2):103–107. doi:10.3928/23258160-20160126-01.
   PubMed Web of Science ®Google Scholar
• Hao X, Yi C, Wang Y, et al. Identification of intraocular inflammatory mediators in patients with endophthalmitis. Mol Vis. 2016;22:563–574.
   PubMed Web of Science ®Google Scholar
• Pleyer U, Ruokonen P. Aqueous humor analysis: a diagnostic tool in intraocular inflammation. Klinische Monatsblatter fur Augenheilkunde. 2010;227(12):953–960. doi:10.1055/s-0029-1245927.
   PubMed Web of Science ®Google Scholar
• Nishihori T, Shaheen M, El-Asmar J, Aljurf M, Kharfan-Dabaja MA. Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation. Immunotherapy. 2015;7(10):1059–1071. doi:10.2217/imt.15.70.
   PubMed Web of Science ®Google Scholar
• de la Camara R. CMV in hematopoietic stem cell transplantation. Mediterr J Hematol Infect Dis. 2016;8:e2016031. doi:10.4084/mjhid.2016.031.
   PubMed Web of Science ®Google Scholar
• Al-Omari A, Aljamaan F, Alhazzani W, Salih S, Arabi Y. Cytomegalovirus infection in immunocompetent critically ill adults: literature review. Ann Intensive Care. 2016;6(1):110. doi:10.1186/s13613-016-0207-8.
   PubMedGoogle Scholar
• Rolle A, Brodin P. Immune adaptation to environmental influence: the case of NK cells and HCMV. Trends Immunol. 2016;37(3):233–243. doi:10.1016/j.it.2016.01.005.
   PubMed Web of Science ®Google Scholar
• Pease JE, Sabroe I. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med. 2002;1(1):19–25. doi:10.1007/BF03257159.
   PubMedGoogle Scholar
• Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA. Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009;84(3):353–360. doi:10.1093/cvr/cvp241.
   PubMed Web of Science ®Google Scholar
• DeForge LE, Fantone JC, Kenney JS, Remick DG. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J Clin Invest. 1992;90(5):2123–2129. doi:10.1172/jci116097.
   PubMed Web of Science ®Google Scholar
• Miao H, Hou J. Influent factors for treating procedure of cytomegalovirus retinitis after allogeneic bone marrow hematopoietic stem cell transplantation. Zhonghua Yan Ke Za Zhi. 2017;53:740–745. doi:10.3760/cma.j.0412-4081.2017.10.005.
   PubMedGoogle Scholar
• Zhang Y, Ruan X, Yang W, et al. High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation. BMC Ophthalmol. 2017;17(1):224. doi:10.1186/s12886-017-0622-0.
   PubMedGoogle Scholar